Allergen: | rEur m 2.0101 (Euroglyphus maynei allergen 2) |
Unit: | 250µg |
Source: | E. coli |
Mol. Wt: | 14kD |
Purification: | Purified from inclusion bodies using B-PER Buffer (Pierce). Solubilized rEur m 2 was refolded by dialysis into 20 mM Tris, 1mM EDTA, pH 8.5. Purity >95% by SDS-PAGE. |
Concentration: | See product insert. |
Formulation: | 20 mM Tris-HCl, pH 8.5, sterile filtered. |
Storage: | Store at -20ºC |
Notes: | (1) rEur m 2.0101 is suitable for T-cell or other in vitro studies, but does not react in the Group 2 mite ELISA . (2) Does react with anti-Group 2 mAb DpX which is used for specific IgE measurements in the chimeric ELISA. (3) Not tested for endotoxin. |
Genbank: | |
PDB: | |
Product Resources: | Recombinant Eur m 2 Certificate of Analysis |
Allergens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. | |
References: | |
| |
Indoor Biotechnologies 由三家附属公司组成,INDOOR Biotechnologies Inc.(IBI),位于美国弗吉尼亚州夏洛茨维尔,INDOOR Biotechnologies Limited(IBL)位于英国卡迪夫,INDOOR Biotechnologies India(IBIndia),新设立于班加罗尔。Indoor Biotechnologies 遍布全球,在日本,中国和韩国拥有授权分销商,在全球约50个国家/地区销售。 Indoor Biotechnologies 生产纯化的天然和重组过敏原,用于研究和开发过敏诊断和疫苗。该产品系列目前包括 50 种纯化的过敏原,其制造具有高纯度和生物活性。这包括具有低内毒素含量的 LoTox™ 过敏原,专为过敏和哮喘的免疫学研究而设计。